Skip to main content
Premium Trial:

Request an Annual Quote

Cyntellect Nets $15.5M in New Financing

NEW YORK (GenomeWeb News) – Cytometry workstation products developer Cyntellect has raised $15.5 million in a financing round that could total $18.6 million, according to a filing with the US Securities and Exchange Commission.

The San Diego-based firm offers a core technology that uses microplate-based cytometry to analyze cells for use in diagnostics and therapeutics.

Cyntellect's Celigo cytometer provides a label-free assay for in situ cell counting of live cells by imaging every cell within all areas of multi-well plates and culture flasks, which Cyntellect says cuts out the need for estimation or for forcing the cells into suspension.

The firm did not name the investors involved in the financing round so far.

As GenomeWeb Daily News reported in October, the company has recently opened a European sales office in Newport, UK that will have sales, scientific and service staff in France, Germany, and the Netherlands, and will support the entire EU.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.